Live Breaking News & Updates on Construction Of The Group

Stay updated with breaking news from Construction of the group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Full year results

I am truly proud of the Group s achievements over the period. We not only secured major new partnerships, brought the Oxbox manufacturing facility online in record time and responded to the challenges of the pandemic, but the team has also been able to rapidly work with AstraZeneca to provide a vaccine solution for COVID-19. This is a true testament to the world-class calibre and dedication of our staff in the year that the Group also gained entry to the FTSE250. Looking to the future, with the continued tide of growth in cell and gene therapy, coupled with the Group s leadership position in the lentiviral vector field, we are well positioned to advance both our own proprietary pipeline and that of our current and future partners programmes. ....

United Kingdom , Sam Rasty , Pierre Fabre , Mary Jane Elliott Matthew Neal , Stuart Paynter , Andrew Heath , Roch Doliveux , Oxford Astrazeneca , Oxford Biomedica Lentivector , John Dawson , Martin Diggle , Oxford Biomedica , Bristol Myers Squibb , Lorenzo Tallarigo , Juno Bristol Myers Squibb , Dame Kay Davies , Manufacturing Organisation , Contract Development , Oxford University Jenner Institute , Research Collaborations , Senior Executive Team , Boehringer Ingelheim , Stryker Corporation , Product Development , Juno Therapeutics Bristol Myers Squibb Partnership , Innovation Centre ,

Investegate |Epwin Group PLC Announcements | Epwin Group PLC: Final Results

·
Strong H2 performance, gaining momentum:
o
Revenues up 4% on H2 2019
o
H2 2020 underlying operating profit £11.2 million (H2 2019 £11.8 million)
·
RMI demand quicker to return and stronger than newbuild and social housing
·
Robust
financial position maintained:
o
Strong cash generation
o
Significant headroom in banking facilities of over £50 million at the year end, facilities now extended to June 2024
o
All pre-COVID banking covenants met with no variation or waivers
o
No additional funding has been sought from shareholders or banks
·
Recommencement of dividend payments, with proposed final dividend of 1.00 penny per share

·
Health and safety prioritised in response to the COVID-19 pandemic ....

United Kingdom , City Of , Chris Empson , Christopher Empson , Andrew Eastgate , Jonathan Bednall , Fiona Conroy , John Goold Dominic King , Jon Bednall , Group Consolidated Financial , Epwin Group Plc , Meeting Of The Company , Registrar Of Companies , Epwin Group , B Stratford Court , Cumbria Limited , Construction Products Association , Construction Of The Group , London Stock Exchange , Zeus Capital Limited Joint Broker , Regulatory Information Service , Financial Conduct Authority , United Nations Un Sustainable Development Goals Sdgs , Committee On Climate , Shore Capital Limited Nominated Adviser , Market Abuse ,